Seres Therapeutics Inc MCRB Valuation Ratios and Share Stats

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Seres Therapeutics Inc (MCRB)
Seres Therapeutics Inc (MCRB) Financials

Seres Therapeutics Inc (MCRB)

0.9155

0.00

(0.00%)

Closed December 23 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-37.414	-38.679	-63.835	-55.576	-37.497	-18.796	-71.103	-32.153
Return on Equity (%)	-54.185	-92.464	-1563.806	145.854	-140.995	-42.825	-351.616	667.531
Return on Invested Capital (%)	-59.964	-105.425	-775.382	213.333	-143.198	-44.596	-270.292	-458.809
Operating Margin (%)	-416.291	-278.442	-350.027	-202.223	-259.53	-43.241	-3425.042	-79.595
Net Profit Margin (%)	-420.743	-278.442	-350.027	-203.678	-268.334	-45.249	-3509.498	-90.025
Book Value Per Share	3.287	1.496	-1.174	-0.689	1.911	1.431	0.086	-0.347
Earnings Per Share	-2.269	-2.203	-2.417	-1.002	-0.975	-0.714	-1.998	-0.88
Cash Per Share	1.351	0.89	2.096	0.928	1.269	1.959	1.302	0.99
Working Capital Per Share	4.161	3.043	1.237	0.773	2.431	2.409	0.872	0.594
Operating Profit Per Share	0.539	0.791	0.691	0.492	0.363	1.596	0.057	0.977
EBIT Per Share	-2.269	-2.203	-2.417	-1.002	-0.975	-0.714	-1.998	-0.88
EBITDA Per Share	-2.269	-2.203	-2.417	-1.002	-0.975	-0.714	-1.998	-0.88
Free Cash Flow Per Share	-1.841	-2.267	-2.562	-1.096	-1.04	-0.674	-1.972	-0.866

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	40.36M	40.57M	40.94M	70.14M	91.46M	91.89M	125.22M	N/A

Key Stats and Ratios

Year End December 30 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	125.22M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	13261.686	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	13634.866	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	156.31M
Price to Earnings Ratio	-1.38
Price to Sales Ratio	1.24
Price to Cash Ratio	1.23
Price to Book Ratio	-3.5
Dividend Yield	-

Share Statistics

Shares Outstanding	170.74M
Average Volume (1 week)	2.06M
Average Volume (1 Month)	2.84M
52 Week Change	-31.17%
52 Week High	2.05
52 Week Low	0.54

More Ratios Coming Soon!

Seres Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions